Journal Scans
Rituximab Blocks Protective Serological Response to Influenza A(H1N1) 2009 Vaccination in Lymphoma Patients During or Within Six Months After Treatment
Flu Vaccine not Protective in Rituximab-Treated Lymphoma Patients
OE Yri, D Torfoss, O Hungnes, A Kolstad, et al
20111008
2011 Nov 8
Blood
Rituximab Blocks Protective Serological Response to Influenza A(H1N1) 2009 Vaccination in Lymphoma Patients During or Within Six Months After Treatment
Blood. 2011 Nov 8;[Epub Ahead of Print], OE Yri, D Torfoss, O Hungnes, A Kolstad, et al
TAKE-HOME MESSAGE
Abstract
Abstract
Cancer patients are often encouraged to receive seasonal influenza vaccination. The monoclonal antibody rituximab is widely used in treatment of non-Hodgkin`s lymphoma. This results in a prolonged depletion of normal B cells, which might impair humoral responses. The aim of the present study was to investigate whether lymphoma patients undergoing rituximab-containing treatment regimens or having received such regimens within the last six months were able to mount protective antibody responses to...
